Edition:
United Kingdom

ENDRA Life Sciences Inc (NDRA.OQ)

NDRA.OQ on NASDAQ Stock Exchange Capital Market

4.11USD
15 Dec 2017
Change (% chg)

$-0.52 (-11.23%)
Prev Close
$4.63
Open
$4.57
Day's High
$4.57
Day's Low
$4.06
Volume
8,052
Avg. Vol
3,082
52-wk High
$4.74
52-wk Low
$2.20

Chart for

About

ENDRA Life Sciences Inc. is engaged in commercialization of an enhanced ultrasound technology for the pre-clinical research market. The Company's Nexus 128 system combines light-based thermoacoustics and ultrasound, to address the imaging needs of researchers studying disease models in pre-clinical applications. The Company is... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $12.93
Shares Outstanding(Mil.): 3.91
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

BRIEF-ENDRA Life Sciences reports Q3 loss per share $0.23

* Q3 loss per share $0.23 Source text: [http://bit.ly/2ANFlXF] Further company coverage:

15 Nov 2017

BRIEF-‍Longboard Capital Advisors LLC​ reports 16.7 pct passive stake in Endra Life Sciences as on May 9

* ‍Longboard Capital Advisors LLC​ reports 16.7 percent passive stake in Endra Life Sciences Inc as on May 9, 2017 - SEC filing Source text (http://bit.ly/2unfXrM) Further company coverage:

13 Jul 2017

Earnings vs. Estimates

No consensus analysis data available.